CoChat

Bioinformatics analysis of the serine and glycine pathway in cancer cells

Open access
Antonov, Alexey, Agostini, Massimiliano, Morello, Maria, Minieri, Marilena, Melino, Gerry, Amelio, Ivano · 2014 · Oncotarget
Cited by 80

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

// Alexey Antonov 1, * , Massimiliano Agostini 1, 2, * , Maria Morello 2 , Marilena Minieri 2 , Gerry Melino 1, 2, 3 , Ivano Amelio 1 1 Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK 2 Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome 00133, Italy 3 Biochemistry Laboratory IDI-IRCC, University of Rome “Tor Vergata”, Rome 00133, Italy * These authors contributed equally to this work Correspondence to: Massimiliano Agostini, e-mail: ma285@le.ac.uk Alexey Antonov, e-mail: aa668@le.ac.uk Keywords: Cancer Metabolism, Serine, Glycine, survival analysis Received: October 27, 2014 Accepted: October 28, 2014 Published: November 21, 2014 ABSTRACT Serine and glycine are amino acids that provide the essential precursors for the synthesis of proteins, nucleic acids and lipids. Employing 3 subsequent enzymes, phosphoglycerate dehydrogenase (PHGDH), phosphoserine phosphatase (PSPH), phosphoserine aminotransferase 1 (PSAT1), 3-phosphoglycerate from glycolysis can be converted in serine, which in turn can by converted in glycine by serine methyl transferase (SHMT). Besides proving precursors for macromolecules, serine/glycine biosynthesis is also required for the maintenance of cellular redox state. Therefore, this metabolic pathway has a pivotal role in proliferating cells, including cancer cells. In the last few years an emerging literature provides genetic and functional evidences that hyperactivation of serine/glycine biosynthetic pathway drives tumorigenesis. Here, we extend these observations performing a bioinformatics analysis using public cancer datasets. Our analysis highlighted the relevance of PHGDH and SHMT2 expression as prognostic factor for breast cancer, revealing a substantial ability of these enzymes to predict patient survival outcome. However analyzing patient datasets of lung cancer our analysis reveled that some other enzymes of the pathways, rather than PHGDH, might be associated to prognosis. Although these observations require further investigations they might suggest a selective requirement of some enzymes in specific cancer types, recommending more cautions in the development of novel translational opportunities and biomarker identification of human cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2668

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

Metadata

Authors
Antonov, A., Agostini, M., Morello, M., Minieri, M., Melino, G., & Amelio, I.
Venue
Oncotarget
Published
2014-11-21
Volume
5
Issue
22
Pages
11004-11013
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2114596030
Cited by
80
References
15
FWCI
3.01
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.